Epigenetics Market by Product & Service (Enzymes, Kits & Reagents, Software), Method, Technique, Application, End User - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 GLOBAL MARKET SIZE ESTIMATION
  • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
  • 2.2.3 SEGMENTAL MARKET ASSESSMENT
• 2.3 GROWTH FORECAST MODEL
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 EPIGENETICS MARKET OVERVIEW
• 4.2 NORTH AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY
• 4.3 EPIGENETICS PRODUCT MARKET, BY END USER, 2024
• 4.4 EPIGENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Declining sequencing costs and time
    • 5.2.1.2 Growing emphasis on population-scale screening initiatives
    • 5.2.1.3 Technological advancements in epigenetics research
    • 5.2.1.4 Rising demand for epigenetic drugs and epigenetic-based therapeutics
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Limited applications of epigenomic data in toxicology
    • 5.2.2.2 Data privacy concerns and security issues
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emerging applications of epigenetics
    • 5.2.3.2 Integration of multi-omics
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Concerns regarding quality of antibodies
    • 5.2.4.2 Challenges associated with epigenetic editing
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 INVESTMENT AND FUNDING SCENARIO
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Single-cell sequencing
    • 5.8.1.2 Chromatin immunoprecipitation
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 DNA methylation microarrays
    • 5.8.2.2 CRISPR-based genome editing
• 5.9 PATENT ANALYSIS
• 5.10 TRADE DATA ANALYSIS
  • 5.10.1 IMPORT DATA
  • 5.10.2 EXPORT DATA
• 5.11 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.12 TARIFF AND REGULATORY LANDSCAPE
  • 5.12.1 TARIFF DATA FOR HS CODES 9027.50.80 AND 3822.00
  • 5.12.2 REGULATORY FRAMEWORK
  • 5.12.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 BARGAINING POWER OF SUPPLIERS
  • 5.13.2 BARGAINING POWER OF BUYERS
  • 5.13.3 THREAT OF NEW ENTRANTS
  • 5.13.4 THREAT OF SUBSTITUTES
  • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 KEY BUYING CRITERIA
• 5.15 IMPACT OF AI/GEN AI ON EPIGENETICS MARKET
  • 5.15.1 INTRODUCTION
  • 5.15.2 MARKET POTENTIAL OF AI IN EPIGENETICS
  • 5.15.3 AI USE CASES
  • 5.15.4 KEY COMPANIES IMPLEMENTING AI/GEN AI
  • 5.15.5 FUTURE OF AI/GEN AI IN EPIGENETICS MARKET
• 5.16 IMPACT OF 2025 US TARIFF
  • 5.16.1 INTRODUCTION
  • 5.16.2 KEY TARIFF RATES
  • 5.16.3 PRICE IMPACT ANALYSIS
  • 5.16.4 KEY IMPACTS ON VARIOUS REGIONS
    • 5.16.4.1 US
    • 5.16.4.2 Europe
    • 5.16.4.3 Asia Pacific
  • 5.16.5 END-USE INDUSTRY IMPACT
    • 5.16.5.1 Pharmaceutical and biotech companies
    • 5.16.5.2 Contract Research Organizations (CROs)
    • 5.16.5.3 Academic and research institutes

6 EPIGENETICS MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 KITS & REAGENTS
  • 6.2.1 ANTIBODIES
    • 6.2.1.1 Growing demand for recombinant antibodies for detection of epigenetic targets to propel market
  • 6.2.2 CHIP-SEQUENCING KITS & REAGENTS
    • 6.2.2.1 Versatile applications of chromatin immunoprecipitation pertaining to epigenetic regulatory systems to boost market
  • 6.2.3 BISULFITE CONVERSION KITS & REAGENTS
    • 6.2.3.1 Effective outcomes associated with bisulfite conversion to sustain growth
  • 6.2.4 WHOLE-GENOME AMPLIFICATION KITS & REAGENTS
    • 6.2.4.1 Ability to maintain relative proportions of genes in original pool to stimulate growth
  • 6.2.5 5-HMC & 5-MC ANALYSIS KITS & REAGENTS
    • 6.2.5.1 Introduction of unique kits for 5-mC and 5-hmC analysis to support growth
  • 6.2.6 HISTONES
    • 6.2.6.1 Emerging importance of chromatin-associated proteins and histones in epigenetic research to bolster growth
  • 6.2.7 OTHER KITS & REAGENTS
• 6.3 ENZYMES
  • 6.3.1 DNA-MODIFYING ENZYMES
    • 6.3.1.1 Broadening applications of DNA methylation to facilitate growth
  • 6.3.2 PROTEIN-MODIFYING ENZYMES
    • 6.3.2.1 Increasing pipeline of epigenetics-based drugs targeting histone-modifying enzymes to spur growth
  • 6.3.3 OTHER ENZYMES
• 6.4 INSTRUMENTS & ACCESSORIES
  • 6.4.1 WIDE USAGE OF NGS INSTRUMENTS AND SONICATORS TO EXPEDITE GROWTH
• 6.5 SOFTWARE
  • 6.5.1 DEVELOPMENT OF VIABLE SOFTWARE SOLUTIONS FOR DNA METHYLATION AND RNA ANALYSIS TO PROMOTE GROWTH
• 6.6 SERVICES
  • 6.6.1 EXPANDING POOL OF SERVICE PROVIDERS TO DRIVE MARKET

7 EPIGENETICS MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 NEXT-GENERATION SEQUENCING (NGS)
  • 7.2.1 INCREASING LAUNCHES OF NEXT-GENERATION SEQUENCING PLATFORMS TO FACILITATE GROWTH
• 7.3 PCR & QPCR
  • 7.3.1 RISING NUMBER OF PCR-BASED EPIGENETICS SERVICE PROVIDERS TO DRIVE MARKET
• 7.4 MASS SPECTROMETRY
  • 7.4.1 GROWING DEMAND FOR MASS SPECTROMETRY IN COMPREHENSIVE STUDIES ON HISTONE EPIGENETICS TO BOOST MARKET
• 7.5 SONICATION
  • 7.5.1 RISING USE OF SONICATION IN SCIENTIFIC AND INDUSTRIAL SETTINGS TO EXPEDITE GROWTH
• 7.6 OTHER TECHNOLOGIES

8 EPIGENETICS MARKET, BY METHOD

• 8.1 INTRODUCTION
• 8.2 DNA METHYLATION
  • 8.2.1 INCREASING RESEARCH & DEVELOPMENT ACTIVITIES TO SPUR GROWTH
• 8.3 HISTONE MODIFICATIONS
  • 8.3.1 GROWING TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
• 8.4 OTHER METHODS

9 EPIGENETICS MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 ONCOLOGY
  • 9.2.1 GROWING INVESTMENT IN EPIGENETIC-BASED RESEARCH TO BOOST MARKET
• 9.3 METABOLIC DISEASES
  • 9.3.1 EMERGING ROLE OF DNA METHYLATION IN DIABETES MANAGEMENT TO FAVOR GROWTH
• 9.4 IMMUNOLOGY
  • 9.4.1 GROWING DEMAND FOR EPIGENETIC PRODUCTS IN TUMOR AND TRANSPLANTATION IMMUNOLOGY TO DRIVE MARKET
• 9.5 DEVELOPMENTAL BIOLOGY
  • 9.5.1 INCREASING RESEARCH ON CELL GROWTH AND DIFFERENTIATION TO PROPEL MARKET
• 9.6 CARDIOVASCULAR DISEASES
  • 9.6.1 EMERGING ROLE OF EPIGENETICS IN UNDERSTANDING ETIOLOGY OF CARDIOVASCULAR DISEASES TO AID GROWTH
• 9.7 OTHER APPLICATIONS

10 EPIGENETICS PRODUCTS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 ACADEMIC & RESEARCH INSTITUTES
  • 10.2.1 INCREASING PUBLIC-PRIVATE COLLABORATIONS TO FAVOR GROWTH
• 10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3.1 GROWING NUMBER OF CLINICAL TRIALS FOR EPIGENETIC-BASED DRUGS TO FUEL MARKET
• 10.4 HOSPITALS & CLINICS
  • 10.4.1 GROWING USE OF PERSONALIZED MEDICINE TO PROPEL MARKET
• 10.5 CONTRACT RESEARCH ORGANIZATIONS
  • 10.5.1 INCREASING DEMAND FOR SCALABLE, HIGH-THROUGHPUT EPIGENETICS KITS TO PROMOTE GROWTH

11 EPIGENETICS SERVICE MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 11.2.1 RISING DEMAND FOR THERAPEUTIC DISCOVERIES TO BOLSTER GROWTH
• 11.3 ACADEMIC & RESEARCH INSTITUTES
  • 11.3.1 INCREASING VOLUME OF HIGH-THROUGHPUT EPIGENOMIC DATA TO AUGMENT GROWTH
• 11.4 HOSPITALS & CLINICS
  • 11.4.1 INCREASING INTEGRATION OF EPIGENETIC ASSAYS INTO CLINICAL DIAGNOSTICS, PROGNOSTICS, AND PERSONALIZED MEDICINE TO AID GROWTH

12 EPIGENETICS MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 Strong network of well-established epigenetic product manufacturers to spur growth
  • 12.2.3 CANADA
    • 12.2.3.1 Favorable government initiatives to contribute to growth
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.3.2 GERMANY
    • 12.3.2.1 Significant investments in next-generation sequencing to bolster growth
  • 12.3.3 UK
    • 12.3.3.1 Rising acceptance of genome-based diagnostic techniques to support growth
  • 12.3.4 FRANCE
    • 12.3.4.1 Growing demand for PCR technologies to drive market
  • 12.3.5 ITALY
    • 12.3.5.1 High incidence of cancer to expedite growth
  • 12.3.6 SPAIN
    • 12.3.6.1 Well-established network of research centers and universities to boost market
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 CHINA
    • 12.4.2.1 High demand for personalized medicine to accelerate growth
  • 12.4.3 JAPAN
    • 12.4.3.1 Increasing collaborations between research & academic organizations to favor growth
  • 12.4.4 INDIA
    • 12.4.4.1 Expanding base of biotechnology facilities to drive market
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Growing hub for epigenetics to propel market
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 Rising burden of chronic diseases to foster growth
  • 12.4.7 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Increasing number of healthcare providers incorporating epigenetic testing to aid growth
  • 12.5.3 MEXICO
    • 12.5.3.1 Growing adoption of cutting-edge technologies to drive market
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST
  • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Saudi Arabia
      • 12.6.2.1.1 Growing healthcare expenditure to propel market
    • 12.6.2.2 UAE
      • 12.6.2.2.1 Increasing collaborations between public and private sectors to spur growth
    • 12.6.2.3 Rest of GCC countries
  • 12.6.3 REST OF MIDDLE EAST
• 12.7 AFRICA
  • 12.7.1 RISING DEMAND FOR TARGETED THERAPIES TO AUGMENT GROWTH
  • 12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 KEY PLAYER STRATEGIES
• 13.3 REVENUE ANALYSIS
• 13.4 MARKET SHARE ANALYSIS
• 13.5 COMPANY VALUATION AND FINANCIAL METRICS
• 13.6 BRAND/PRODUCT COMPARISON
  • 13.6.1 THERMO FISHER SCIENTIFIC INC.
  • 13.6.2 ILLUMINA, INC.
  • 13.6.3 MERCK KGAA
  • 13.6.4 DANAHER
• 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 13.7.1 STARS
  • 13.7.2 EMERGING LEADERS
  • 13.7.3 PERVASIVE PLAYERS
  • 13.7.4 PARTICIPANTS
  • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 13.7.5.1 Company footprint
    • 13.7.5.2 Region footprint
    • 13.7.5.3 Offering footprint
    • 13.7.5.4 Method footprint
    • 13.7.5.5 Technology footprint
• 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 13.8.1 PROGRESSIVE COMPANIES
  • 13.8.2 RESPONSIVE COMPANIES
  • 13.8.3 DYNAMIC COMPANIES
  • 13.8.4 STARTING BLOCKS
  • 13.8.5 COMPETITIVE BENCHMARKING
    • 13.8.5.1 Detailed list of key startups/SMEs
    • 13.8.5.2 Competitive benchmarking of key startups/SMEs
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

• 14.1 KEY MARKET PLAYERS
  • 14.1.1 THERMO FISHER SCIENTIFIC INC.
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product launches
      • 14.1.1.3.2 Deals
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Key strengths
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses and competitive threats
  • 14.1.2 ILLUMINA, INC.
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches
      • 14.1.2.3.2 Deals
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Key strengths
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 MERCK KGAA
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 MnM view
      • 14.1.3.3.1 Key strengths
      • 14.1.3.3.2 Strategic choices
      • 14.1.3.3.3 Weaknesses and competitive threats
  • 14.1.4 PACBIO
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Product launches
      • 14.1.4.3.2 Deals
      • 14.1.4.3.3 Expansions
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Key strengths
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses and competitive threats
  • 14.1.5 DANAHER
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Deals
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Key strengths
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses and competitive threats
  • 14.1.6 BIO-RAD LABORATORIES, INC.
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
  • 14.1.7 ACTIVE MOTIF
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Deals
  • 14.1.8 NEW ENGLAND BIOLABS
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Product launches
      • 14.1.8.3.2 Deals
  • 14.1.9 QIAGEN
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Product launches
  • 14.1.10 ZYMO RESEARCH CORPORATION
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Product launches
      • 14.1.10.3.2 Expansions
      • 14.1.10.3.3 Other developments
  • 14.1.11 REVVITY
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Deals
  • 14.1.12 HOLOGIC, INC.
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
  • 14.1.13 F. HOFFMANN-LA ROCHE LTD
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
  • 14.1.14 PROMEGA CORPORATION
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products offered
  • 14.1.15 EPIGENTEK GROUP INC.
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products offered
• 14.2 OTHER PLAYERS
  • 14.2.1 EPICYPHER
  • 14.2.2 FIOS GENOMICS
  • 14.2.3 GENOMESCAN
  • 14.2.4 CREATIVE BIOGENE
  • 14.2.5 BPS BIOSCIENCE, INC.
  • 14.2.6 ABNOVA CORPORATION
  • 14.2.7 CREATIVE DIAGNOSTICS
  • 14.2.8 BIOMODAL
  • 14.2.9 INTEGRATED DNA TECHNOLOGIES, INC.
  • 14.2.10 NOVOGENE CO., LTD.

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

List of Tables

• TABLE 1 EPIGENETICS MARKET: INCLUSIONS AND EXCLUSIONS
• TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
• TABLE 3 EPIGENETICS MARKET: RISK ANALYSIS
• TABLE 4 EPIGENETICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
• TABLE 5 AVERAGE SELLING PRICE TREND OF EPIGENETIC PRODUCTS, BY KEY PLAYER, 2022-2024 (USD MILLION)
• TABLE 6 AVERAGE SELLING PRICE TREND OF EPIGENETIC INSTRUMENTS, BY REGION, 2022-2024 (USD MILLION)
• TABLE 7 AVERAGE SELLING PRICE TREND OF EPIGENETIC KITS AND REAGENTS, BY REGION, 2022-2024 (USD MILLION)
• TABLE 8 AVERAGE SELLING PRICE TREND OF EPIGENETIC ENZYMES, BY REGION, 2022-2024 (USD MILLION)
• TABLE 9 EPIGENETICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 10 EPIGENETICS MARKET: INVESTMENT AND FUNDING SCENARIO OF KEY PLAYERS, 2022-2025
• TABLE 11 EPIGENETICS MARKET: PATENTS FILED GLOBALLY, 2014-2024
• TABLE 12 EPIGENETICS MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2024-2025
• TABLE 13 IMPORT VALUE OF HS CODE 9027.50- COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND)
• TABLE 14 IMPORT VALUE OF HS CODE 382.00- COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND)
• TABLE 15 EXPORT VALUE OF HS CODE 9027.50 - COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND)
• TABLE 16 EXPORT VALUE OF HS CODE 3822.00 - COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND)
• TABLE 17 EPIGENETICS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
• TABLE 18 TARIFF DATA FOR HS CODES 9027.50.80 AND 3822.00
• TABLE 19 KEY REGULATORY AGENCIES
• TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 24 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 25 AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 26 EPIGENETICS MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
• TABLE 28 KEY BUYING CRITERIA, BY END USER
• TABLE 29 LIST OF COMPANIES IMPLEMENTING AI/GEN AI IN EPIGENETICS MARKET
• TABLE 30 US ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 31 EXPORTS AND IMPORTS, BY REGION, 2024-2025
• TABLE 32 KEY PRODUCT-RELATED TARIFF: HS CODES FOR PRODUCTS RELEVANT TO EPIGENETICS
• TABLE 33 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
• TABLE 34 EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 35 EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 36 EPIGENETICS MARKET FOR KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 37 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 38 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 39 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 40 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 41 MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 42 GCC COUNTRIES: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 43 EPIGENETICS MARKET FOR ANTIBODIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 44 NORTH AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 45 EUROPE: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 46 ASIA PACIFIC: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 47 LATIN AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 48 MIDDLE EAST: EPIGENETICS MARKET FOR ANTIBODIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 49 GCC COUNTRIES: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 50 EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 51 NORTH AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 52 EUROPE: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 53 ASIA PACIFIC: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 54 LATIN AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 55 MIDDLE EAST: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 56 GCC COUNTRIES: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 58 NORTH AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 59 EUROPE: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 60 ASIA PACIFIC: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 61 LATIN AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 62 MIDDLE EAST: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 63 GCC COUNTRIES: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 64 EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 65 NORTH AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 66 EUROPE: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 67 ASIA PACIFIC: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 68 LATIN AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 69 MIDDLE EAST: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 70 GCC COUNTRIES: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 71 EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 72 NORTH AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 73 EUROPE: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 74 ASIA PACIFIC: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 75 LATIN AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 76 MIDDLE EAST: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 77 GCC COUNTRIES: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 78 EPIGENETICS MARKET FOR HISTONES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 79 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 80 EUROPE: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 81 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 82 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 83 MIDDLE EAST: EPIGENETICS MARKET FOR HISTONES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 84 GCC COUNTRIES: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 85 EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 86 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 87 EUROPE: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 88 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 89 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 90 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 91 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 92 EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 93 EPIGENETICS MARKET FOR ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 94 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 95 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 96 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 97 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 98 MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 99 GCC COUNTRIES: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 100 EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 101 NORTH AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 102 EUROPE: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 103 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 104 LATIN AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 105 MIDDLE EAST: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 106 GCC COUNTRIES: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 107 EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 108 NORTH AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 109 EUROPE: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 110 ASIA PACIFIC: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 111 LATIN AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 112 MIDDLE EAST: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 113 GCC COUNTRIES: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 114 EPIGENETICS MARKET FOR OTHER ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 115 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 116 EUROPE: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 117 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 118 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 119 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER ENZYMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 120 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 121 EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 122 NORTH AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 123 EUROPE: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 124 ASIA PACIFIC: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 125 LATIN AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 126 MIDDLE EAST: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 127 GCC COUNTRIES: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 128 EPIGENETICS MARKET FOR SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
• TABLE 129 NORTH AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 130 EUROPE: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 131 ASIA PACIFIC: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 132 LATIN AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 133 MIDDLE EAST: EPIGENETICS MARKET FOR SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
• TABLE 134 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 135 EPIGENETICS MARKET FOR SERVICES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 136 NORTH AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 137 EUROPE: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 138 ASIA PACIFIC: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 139 LATIN AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 140 MIDDLE EAST: EPIGENETICS MARKET FOR SERVICES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 141 GCC COUNTRIES: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 142 EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 143 EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2023-2030 (USD MILLION)
• TABLE 144 NORTH AMERICA: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 145 EUROPE: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 146 ASIA PACIFIC: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 147 LATIN AMERICA: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 148 MIDDLE EAST: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2023-2030 (USD MILLION)
• TABLE 149 GCC COUNTRIES: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 150 EPIGENETICS MARKET FOR PCR & QPCR, BY REGION, 2023-2030 (USD MILLION)
• TABLE 151 NORTH AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 152 EUROPE: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 153 ASIA PACIFIC: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 154 LATIN AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 155 MIDDLE EAST: EPIGENETICS MARKET FOR PCR & QPCR, BY REGION, 2023-2030 (USD MILLION)
• TABLE 156 GCC COUNTRIES: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 157 EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 158 NORTH AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 159 EUROPE: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 160 ASIA PACIFIC: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 161 LATIN AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 162 MIDDLE EAST: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 163 GCC COUNTRIES: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 164 EPIGENETICS MARKET FOR SONICATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 165 NORTH AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 166 EUROPE: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 167 ASIA PACIFIC: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 168 LATIN AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 169 MIDDLE EAST: EPIGENETICS MARKET FOR SONICATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 170 GCC COUNTRIES: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 171 EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 172 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 173 EUROPE: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 174 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 175 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 176 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 177 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 178 EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 179 EPIGENETICS MARKET FOR DNA METHYLATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 180 NORTH AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 181 EUROPE: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 182 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 183 LATIN AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 184 MIDDLE EAST: EPIGENETICS MARKET FOR DNA METHYLATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 185 GCC COUNTRIES: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 186 COMMON HISTONE MODIFICATIONS AND RESPECTIVE LOCATIONS
• TABLE 187 EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 188 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 189 EUROPE: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 190 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 191 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 192 MIDDLE EAST: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 193 GCC COUNTRIES: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 194 EPIGENETICS MARKET FOR OTHER METHODS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 195 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 196 EUROPE: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 197 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 198 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 199 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER METHODS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 200 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 201 EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 202 EPIGENOME-TARGETING CANCER DRUGS APPROVED OR IN CLINICAL TRIALS
• TABLE 203 EPIGENETICS MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 204 NORTH AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 205 EUROPE: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 206 ASIA PACIFIC: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 207 LATIN AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 208 MIDDLE EAST: EPIGENETICS MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 209 GCC COUNTRIES: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 210 EPIGENETICS MARKET FOR METABOLIC DISEASES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 211 NORTH AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 212 EUROPE: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 213 ASIA PACIFIC: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 214 LATIN AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 215 MIDDLE EAST: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 216 GCC COUNTRIES: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 217 EPIGENETICS MARKET FOR IMMUNOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 218 NORTH AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 219 EUROPE: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 220 ASIA PACIFIC: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 221 LATIN AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 222 MIDDLE EAST: EPIGENETICS MARKET FOR IMMUNOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 223 GCC COUNTRIES: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 224 EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 225 NORTH AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 226 EUROPE: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 227 ASIA PACIFIC: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 228 LATIN AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 229 MIDDLE EAST: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 230 GCC COUNTRIES: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 231 EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 232 NORTH AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 233 EUROPE: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 234 ASIA PACIFIC: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 235 LATIN AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 236 MIDDLE EAST: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 237 GCC COUNTRIES: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 238 EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 239 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 240 EUROPE: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 241 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 242 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 243 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 244 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 245 EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 246 EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 247 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 248 EUROPE: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 249 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 250 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 251 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 252 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 253 EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 254 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 255 EUROPE: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 256 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 257 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 258 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 259 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 260 EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 261 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 262 EUROPE: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 263 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 264 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 265 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 266 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 267 EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 268 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 269 EUROPE: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 270 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 271 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 272 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 273 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 274 EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 275 EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 276 NORTH AMERICA: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 277 EUROPE: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 278 ASIA PACIFIC: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 279 LATIN AMERICA: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 280 MIDDLE EAST: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 281 GCC COUNTRIES: EPIGENETICS SERVICE MARKET PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 282 EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 283 NORTH AMERICA: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 284 EUROPE: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 285 ASIA PACIFIC: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 286 LATIN AMERICA: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 287 MIDDLE EAST: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 288 GCC COUNTRIES: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 289 EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 290 NORTH AMERICA: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 291 EUROPE: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 292 ASIA PACIFIC: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 293 LATIN AMERICA: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 294 MIDDLE EAST: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 295 GCC COUNTRIES: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 296 EPIGENETICS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 297 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
• TABLE 298 NORTH AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 299 NORTH AMERICA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 300 NORTH AMERICA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 301 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 302 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 303 NORTH AMERICA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 304 NORTH AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 305 NORTH AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 306 NORTH AMERICA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 307 NORTH AMERICA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 308 US: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 309 US: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 310 US: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 311 US: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 312 US: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 313 US: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 314 US: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 315 US: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 316 US: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 317 CANADA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 318 CANADA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 319 CANADA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 320 CANADA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 321 CANADA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 322 CANADA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 323 CANADA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 324 CANADA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 325 CANADA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 326 EUROPE: KEY MACROECONOMIC INDICATORS
• TABLE 327 EUROPE: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 328 EUROPE: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 329 EUROPE: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 330 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 331 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 332 EUROPE: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 333 EUROPE: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 334 EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 335 EUROPE: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 336 EUROPE: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 337 GERMANY: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 338 GERMANY: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 339 GERMANY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 340 GERMANY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 341 GERMANY: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 342 GERMANY: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 343 GERMANY: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 344 GERMANY: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 345 GERMANY: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 346 UK: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 347 UK: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 348 UK: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 349 UK: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 350 UK: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 351 UK: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 352 UK: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 353 UK: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 354 UK: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 355 FRANCE: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 356 FRANCE: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 357 FRANCE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 358 FRANCE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 359 FRANCE: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 360 FRANCE: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 361 FRANCE: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 362 FRANCE: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 363 FRANCE: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 364 ITALY: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 365 ITALY: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 366 ITALY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 367 ITALY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 368 ITALY: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 369 ITALY: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 370 ITALY: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 371 ITALY: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 372 ITALY: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 373 SPAIN: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 374 SPAIN: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 375 SPAIN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 376 SPAIN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 377 SPAIN: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 378 SPAIN: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 379 SPAIN: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 380 SPAIN: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 381 SPAIN: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 382 REST OF EUROPE: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 383 REST OF EUROPE: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 384 REST OF EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 385 REST OF EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 386 REST OF EUROPE: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 387 REST OF EUROPE: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 388 REST OF EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 389 REST OF EUROPE: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 390 REST OF EUROPE: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 391 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
• TABLE 392 ASIA PACIFIC: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 393 ASIA PACIFIC: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 394 ASIA PACIFIC: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 395 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 396 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 397 ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 398 ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 399 ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 400 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 401 ASIA PACIFIC: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 402 CHINA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 403 CHINA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 404 CHINA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 405 CHINA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 406 CHINA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 407 CHINA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 408 CHINA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 409 CHINA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 410 CHINA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 411 JAPAN: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 412 JAPAN: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 413 JAPAN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 414 JAPAN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 415 JAPAN: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 416 JAPAN: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 417 JAPAN: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 418 JAPAN: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 419 JAPAN: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 420 INDIA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 421 INDIA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 422 INDIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 423 INDIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 424 INDIA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 425 INDIA: EPIGENETICS MARKET, BY TECHNOLOGY 2023-2030 (USD MILLION)
• TABLE 426 INDIA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 427 INDIA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 428 INDIA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 429 AUSTRALIA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 430 AUSTRALIA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 431 AUSTRALIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 432 AUSTRALIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 433 AUSTRALIA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 434 AUSTRALIA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 435 AUSTRALIA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 436 AUSTRALIA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 437 AUSTRALIA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 438 SOUTH KOREA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 439 SOUTH KOREA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 440 SOUTH KOREA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 441 SOUTH KOREA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 442 SOUTH KOREA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 443 SOUTH KOREA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 444 SOUTH KOREA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 445 SOUTH KOREA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 446 SOUTH KOREA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 447 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 448 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 449 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 450 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 451 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 452 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 453 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 454 REST OF ASIA PACIFIC: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 455 REST OF ASIA PACIFIC: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 456 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
• TABLE 457 LATIN AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 458 LATIN AMERICA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 459 LATIN AMERICA: EPIGENETICS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 460 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 461 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 462 LATIN AMERICA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 463 LATIN AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 464 LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 465 LATIN AMERICA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 466 LATIN AMERICA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 467 BRAZIL: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 468 BRAZIL: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 469 BRAZIL: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 470 BRAZIL: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 471 BRAZIL: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 472 BRAZIL: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 473 BRAZIL: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 474 BRAZIL: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 475 BRAZIL: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 476 MEXICO: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 477 MEXICO: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 478 MEXICO: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 479 MEXICO: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 480 MEXICO: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 481 MEXICO: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 482 MEXICO: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 483 MEXICO: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 484 MEXICO: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 485 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 486 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 487 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 488 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 489 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 490 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 491 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 492 REST OF LATIN AMERICA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 493 REST OF LATIN AMERICA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 494 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
• TABLE 495 MIDDLE EAST: EPIGENETICS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 496 MIDDLE EAST: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 497 MIDDLE EAST: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 498 MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 499 MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 500 MIDDLE EAST: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 501 MIDDLE EAST: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 502 MIDDLE EAST: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 503 MIDDLE EAST: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 504 MIDDLE EAST: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 505 GCC COUNTRIES: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 506 GCC COUNTRIES: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 507 GCC COUNTRIES: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 508 GCC COUNTRIES: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 509 GCC COUNTRIES: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 510 GCC COUNTRIES: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 511 GCC COUNTRIES: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 512 GCC COUNTRIES: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 513 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 514 GCC COUNTRIES: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 515 SAUDI ARABIA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 516 SAUDI ARABIA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 517 SAUDI ARABIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 518 SAUDI ARABIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 519 SAUDI ARABIA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 520 SAUDI ARABIA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 521 SAUDI ARABIA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 522 SAUDI ARABIA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 523 SAUDI ARABIA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 524 UAE: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 525 UAE: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 526 UAE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 527 UAE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 528 UAE: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 529 UAE: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 530 UAE: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 531 UAE: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 532 UAE: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 533 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 534 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 535 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 536 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 537 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 538 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 539 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 540 REST OF GCC COUNTRIES: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 541 REST OF GCC COUNTRIES: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 542 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 543 REST OF MIDDLE EAST: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 544 REST OF MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 545 REST OF MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 546 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 547 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 548 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 549 REST OF MIDDLE EAST: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 550 REST OF MIDDLE EAST: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 551 AFRICA: KEY MACROECONOMIC INDICATORS
• TABLE 552 AFRICA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 553 AFRICA: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 554 AFRICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 555 AFRICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 556 AFRICA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 557 AFRICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 558 AFRICA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 559 AFRICA: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 560 AFRICA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 561 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EPIGENETICS MARKET, JANUARY 2022-JULY 2025
• TABLE 562 EPIGENETICS MARKET: DEGREE OF COMPETITION
• TABLE 563 EPIGENETICS MARKET: REGION FOOTPRINT
• TABLE 564 EPIGENETICS MARKET: OFFERING FOOTPRINT
• TABLE 565 EPIGENETICS MARKET: METHOD FOOTPRINT
• TABLE 566 EPIGENETICS MARKET: TECHNOLOGY FOOTPRINT
• TABLE 567 EPIGENETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 568 EPIGENETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• TABLE 569 EPIGENETICS MARKET: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 570 EPIGENETICS MARKET: DEALS, JANUARY 2022-JULY 2025
• TABLE 571 EPIGENETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025
• TABLE 572 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• TABLE 573 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
• TABLE 574 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 575 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-JULY 2025
• TABLE 576 ILLUMINA, INC.: COMPANY OVERVIEW
• TABLE 577 ILLUMINA, INC.: PRODUCTS OFFERED
• TABLE 578 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 579 ILLUMINA, INC.: DEALS, JANUARY 2022-JULY 2025
• TABLE 580 MERCK KGAA: COMPANY OVERVIEW
• TABLE 581 MERCK KGAA: PRODUCTS OFFERED
• TABLE 582 PACBIO: COMPANY OVERVIEW
• TABLE 583 PACBIO: PRODUCTS OFFERED
• TABLE 584 PACBIO: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 585 PACBIO: DEALS, JANUARY 2022-JULY 2025
• TABLE 586 PACBIO: EXPANSIONS, JANUARY 2022- JULY 2025
• TABLE 587 DANAHER: COMPANY OVERVIEW
• TABLE 588 DANAHER: PRODUCTS OFFERED
• TABLE 589 DANAHER: DEALS, JANUARY 2022-JULY 2025
• TABLE 590 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
• TABLE 591 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
• TABLE 592 ACTIVE MOTIF: COMPANY OVERVIEW
• TABLE 593 ACTIVE MOTIF: PRODUCTS OFFERED
• TABLE 594 ACTIVE MOTIF: DEALS, JANUARY 2022-JULY 2025
• TABLE 595 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
• TABLE 596 NEW ENGLAND BIOLABS: PRODUCTS OFFERED
• TABLE 597 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 598 NEW ENGLAND BIOLABS: DEALS, JANUARY 2022-JULY 2025
• TABLE 599 QIAGEN: COMPANY OVERVIEW
• TABLE 600 QIAGEN: PRODUCTS OFFERED
• TABLE 601 QIAGEN: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 602 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
• TABLE 603 ZYMO RESEARCH CORPORATION: PRODUCTS OFFERED
• TABLE 604 ZYMO RESEARCH CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 605 ZYMO RESEARCH CORPORATION: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 606 ZYMO RESEARCH CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025
• TABLE 607 REVVITY: COMPANY OVERVIEW
• TABLE 608 REVVITY: PRODUCTS OFFERED
• TABLE 609 REVVITY: DEALS, JANUARY 2022-JULY 2025
• TABLE 610 HOLOGIC, INC. COMPANY OVERVIEW
• TABLE 611 HOLOGIC, INC.: PRODUCTS OFFERED
• TABLE 612 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW
• TABLE 613 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
• TABLE 614 PROMEGA CORPORATION: COMPANY OVERVIEW
• TABLE 615 PROMEGA CORPORATION: PRODUCTS OFFERED
• TABLE 616 EPIGENTEK GROUP INC.: COMPANY OVERVIEW
• TABLE 617 EPIGENTEK GROUP INC.: PRODUCTS OFFERED
• TABLE 618 EPICYPHER: COMPANY OVERVIEW
• TABLE 619 FIOS GENOMICS: COMPANY OVERVIEW
• TABLE 620 GENOMESCAN: COMPANY OVERVIEW
• TABLE 621 CREATIVE BIOGENE: COMPANY OVERVIEW
• TABLE 622 BPS BIOSCIENCE, INC.: COMPANY OVERVIEW
• TABLE 623 ABNOVA CORPORATION: COMPANY OVERVIEW
• TABLE 624 CREATIVE DIAGNOSTICS: COMPANY OVERVIEW
• TABLE 625 BIOMODAL: COMPANY OVERVIEW
• TABLE 626 INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 627 NOVOGENE CO., LTD.: COMPANY OVERVIEW

List of Figures

• FIGURE 1 EPIGENETICS MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 EPIGENETICS MARKET: YEARS CONSIDERED
• FIGURE 3 EPIGENETICS MARKET: RESEARCH DESIGN
• FIGURE 4 EPIGENETICS MARKET: BREAKDOWN OF PRIMARIES
• FIGURE 5 EPIGENETICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
• FIGURE 6 EPIGENETICS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2024
• FIGURE 7 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE ANALYSIS, 2024
• FIGURE 8 EPIGENETICS MARKET: INSIGHTS FROM PRIMARY EXPERTS
• FIGURE 9 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
• FIGURE 10 EPIGENETICS MARKET: CAGR PROJECTIONS
• FIGURE 11 EPIGENETICS MARKET: DATA TRIANGULATION
• FIGURE 12 EPIGENETICS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
• FIGURE 13 EPIGENETICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
• FIGURE 14 EPIGENETICS MARKET, BY METHOD, 2025 VS. 2030 (USD MILLION)
• FIGURE 15 EPIGENETICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
• FIGURE 16 EPIGENETICS PRODUCT MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 17 EPIGENETICS SERVICE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 18 GEOGRAPHIC ANALYSIS OF EPIGENETICS MARKET
• FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN EPIGENETICS RESEARCH TO DRIVE MARKET GROWTH
• FIGURE 20 DNA METHYLATION SEGMENT AND US LED NORTH AMERICAN EPIGENETICS MARKET IN 2024
• FIGURE 21 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 22 ASIA PACIFIC TO BE FASTEST-GROWING MARKET IN GLOBAL EPIGENETICS MARKET DURING FORECAST PERIOD
• FIGURE 23 EPIGENETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 24 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2022
• FIGURE 25 NUMBER OF CANCER CASES IN US, 2019-2024
• FIGURE 26 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN EPIGENETICS MARKET
• FIGURE 27 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD)
• FIGURE 28 AVERAGE SELLING PRICE OF KITS AND REAGENTS, BY KEY PLAYER, 2024 (USD)
• FIGURE 29 AVERAGE SELLING PRICE OF ENZYMES, BY KEY PLAYER, 2024 (USD)
• FIGURE 30 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD MILLION)
• FIGURE 31 AVERAGE SELLING PRICE OF KITS AND REAGENTS, BY REGION, 2024 (USD MILLION)
• FIGURE 32 AVERAGE SELLING PRICE OF ENZYMES, BY REGION, 2024 (USD MILLION)
• FIGURE 33 EPIGENETICS MARKET: VALUE CHAIN ANALYSIS
• FIGURE 34 EPIGENETICS MARKET: ECOSYSTEM ANALYSIS
• FIGURE 35 EPIGENETICS MARKET: INVESTMENT AND FUNDING SCENARIO, 2022-2025
• FIGURE 36 EPIGENETICS MARKET: PATENT ANALYSIS, JANUARY 2014-DECEMBER 2024
• FIGURE 37 EPIGENETICS MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 38 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
• FIGURE 39 KEY BUYING CRITERIA, BY END USER
• FIGURE 40 EPIGENETICS MARKET: AI USE CASES
• FIGURE 41 EPIGENETICS MARKET, BY OFFERING, 2023-2030 (MILLION UNITS)
• FIGURE 42 NORTH AMERICA: EPIGENETICS MARKET SNAPSHOT
• FIGURE 43 ASIA PACIFIC: EPIGENETICS MARKET SNAPSHOT
• FIGURE 44 EPIGENETICS MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022-2024
• FIGURE 45 EPIGENETICS MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
• FIGURE 46 EV/EBITDA OF KEY VENDORS
• FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 48 EPIGENETICS MARKET: BRAND/PRODUCT COMPARISON
• FIGURE 49 EPIGENETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 50 EPIGENETICS MARKET: COMPANY FOOTPRINT
• FIGURE 51 EPIGENETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
• FIGURE 53 ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2024)
• FIGURE 55 PACBIO: COMPANY SNAPSHOT (2024)
• FIGURE 56 DANAHER: COMPANY SNAPSHOT (2024)
• FIGURE 57 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 58 QIAGEN: COMPANY SNAPSHOT (2024)
• FIGURE 59 REVVITY: COMPANY SNAPSHOT (2024)
• FIGURE 60 HOLOGIC, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 61 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2024)